Cardinal Health 414 Drug Patent Portfolio

Cardinal Health 414 owns 1 orange book drug protected by 2 US patents Given below is the list of Cardinal Health 414's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9439985 Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran 30 Jan, 2029
Active
US6409990 Macromolecular carrier for drug and diagnostic agent delivery 12 May, 2025
Active


Given below is the list of recent legal activities going on the following drug patents of Cardinal Health 414.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 13 Mar, 2020 US9439985
Change in Power of Attorney (May Include Associate POA) 05 Jun, 2017 US9439985
Email Notification 05 Jun, 2017 US9439985
Correspondence Address Change 02 Jun, 2017 US9439985
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 27 Mar, 2017 US9439985
Patent Issue Date Used in PTA Calculation 13 Sep, 2016 US9439985
Recordation of Patent Grant Mailed 13 Sep, 2016 US9439985
Email Notification 25 Aug, 2016 US9439985
Issue Notification Mailed 24 Aug, 2016 US9439985
Dispatch to FDC 08 Aug, 2016 US9439985
Application Is Considered Ready for Issue 08 Aug, 2016 US9439985
Issue Fee Payment Verified 05 Aug, 2016 US9439985
Issue Fee Payment Received 05 Aug, 2016 US9439985
Mail Miscellaneous Communication to Applicant 31 May, 2016 US9439985
Email Notification 31 May, 2016 US9439985


Cardinal Health 414's Family Patents

Cardinal Health 414 drugs have patent protection in a total of 8 countries. It's US patent count contributes only to 27.8% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Cardinal Health 414 Drug List

Given below is the complete list of Cardinal Health 414's drugs and the patents protecting them.


1. Lymphoseek Kit

Lymphoseek Kit is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9439985 Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran 30 Jan, 2029
(4 years from now)
Active
US6409990 Macromolecular carrier for drug and diagnostic agent delivery 12 May, 2025
(7 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lymphoseek Kit's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List